Antengene initiates phase II study of ATG-008 in advanced solid tumors with genetic alterations April 12, 2021
Enrollment ongoing in phase I study of tomivosertib plus paclitaxel in advanced breast cancer April 12, 2021
Context Therapeutics and Integral Molecular collaborate to develop novel anti-CLDN6 antibodies April 12, 2021
Treatment with Escozine results in apoptosis of various types of leukemia cancer cell lines April 12, 2021
Coreline wins approval for AI medical solutions suite, enters Taiwanese market April 9, 2021 By Gina Lee HONG KONG – Coreline Soft Co. Ltd. has taken its first step into the Greater China market after receiving approval from Taiwan’s Food and Drug Administration (TFDA) on April 8 for its Aview suite of artificial intelligence (AI) medical solutions. Read More
RSS
